EBRO 2017

Advanced stage disease

• Level II evidence

II IVA S LC S LC S LC III

FIGO 1987-1989

66% 39% 11%

PCS 1973

57% 47%

M.D. Anderson 1975

65% 82% 40% 67%

Washington University

68% 84% 45% 63%

French Co-operative Study 76% 80% 50% 57%